1. Home
  2. SPCB vs INTS Comparison

SPCB vs INTS Comparison

Compare SPCB & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • INTS
  • Stock Information
  • Founded
  • SPCB 1988
  • INTS 2012
  • Country
  • SPCB Israel
  • INTS United States
  • Employees
  • SPCB N/A
  • INTS N/A
  • Industry
  • SPCB Semiconductors
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPCB Technology
  • INTS Health Care
  • Exchange
  • SPCB Nasdaq
  • INTS Nasdaq
  • Market Cap
  • SPCB 31.4M
  • INTS 33.4M
  • IPO Year
  • SPCB N/A
  • INTS 2023
  • Fundamental
  • Price
  • SPCB $10.92
  • INTS $2.45
  • Analyst Decision
  • SPCB Strong Buy
  • INTS Strong Buy
  • Analyst Count
  • SPCB 1
  • INTS 3
  • Target Price
  • SPCB $18.00
  • INTS $8.50
  • AVG Volume (30 Days)
  • SPCB 758.7K
  • INTS 35.2K
  • Earning Date
  • SPCB 11-14-2024
  • INTS 03-13-2025
  • Dividend Yield
  • SPCB N/A
  • INTS N/A
  • EPS Growth
  • SPCB N/A
  • INTS N/A
  • EPS
  • SPCB 1.02
  • INTS N/A
  • Revenue
  • SPCB $26,843,000.00
  • INTS N/A
  • Revenue This Year
  • SPCB $6.72
  • INTS N/A
  • Revenue Next Year
  • SPCB $16.91
  • INTS N/A
  • P/E Ratio
  • SPCB $9.64
  • INTS N/A
  • Revenue Growth
  • SPCB 5.23
  • INTS N/A
  • 52 Week Low
  • SPCB $2.55
  • INTS $1.50
  • 52 Week High
  • SPCB $18.95
  • INTS $5.94
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 45.68
  • INTS 54.12
  • Support Level
  • SPCB $8.72
  • INTS $2.20
  • Resistance Level
  • SPCB $11.43
  • INTS $2.53
  • Average True Range (ATR)
  • SPCB 1.50
  • INTS 0.30
  • MACD
  • SPCB -0.74
  • INTS 0.00
  • Stochastic Oscillator
  • SPCB 2.79
  • INTS 57.80

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

Share on Social Networks: